company background image
JPH

Jerusalem Pharmaceuticals PLSE:JPH Stock Report

Last Price

US$3.28

Market Cap

US$59.0m

7D

0%

1Y

17.6%

Updated

27 Sep, 2022

Data

Company Financials
JPH fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends3/6

JPH Stock Overview

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally.

Jerusalem Pharmaceuticals Co. Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jerusalem Pharmaceuticals
Historical stock prices
Current Share PriceUS$3.28
52 Week HighUS$3.29
52 Week LowUS$2.68
Beta0.11
1 Month Change1.23%
3 Month Change1.55%
1 Year Change17.56%
3 Year Change20.15%
5 Year Change6.49%
Change since IPO166.47%

Recent News & Updates

Shareholder Returns

JPHPS PharmaceuticalsPS Market
7D0%-3.9%-0.7%
1Y17.6%-19.9%8.4%

Return vs Industry: JPH exceeded the PS Pharmaceuticals industry which returned -19.9% over the past year.

Return vs Market: JPH exceeded the PS Market which returned 8.4% over the past year.

Price Volatility

Is JPH's price volatile compared to industry and market?
JPH volatility
JPH Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement2.8%
10% most volatile stocks in PS Market5.6%
10% least volatile stocks in PS Market1.3%

Stable Share Price: Insufficient data to determine JPH's volatility over the past 3 months.

Volatility Over Time: Insufficient data to determine JPH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1969540Mohammed Mahmoud Masroujihttps://www.jepharm.ps

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. The company offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. It produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions.

Jerusalem Pharmaceuticals Co. Ltd. Fundamentals Summary

How do Jerusalem Pharmaceuticals's earnings and revenue compare to its market cap?
JPH fundamental statistics
Market CapUS$59.04m
Earnings (TTM)US$7.81m
Revenue (TTM)US$47.28m

7.6x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
JPH income statement (TTM)
RevenueUS$47.28m
Cost of RevenueUS$22.65m
Gross ProfitUS$24.63m
Other ExpensesUS$16.82m
EarningsUS$7.81m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.43
Gross Margin52.10%
Net Profit Margin16.52%
Debt/Equity Ratio2.9%

How did JPH perform over the long term?

See historical performance and comparison

Dividends

3.7%

Current Dividend Yield

28%

Payout Ratio